Back to Search
STEVEN COME, M.D.
M.D.
Medical Oncology Physician
NPI: 1619940137IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
39433(MA)
Education
HARVARD MEDICAL SCHOOL
Class of 1972
Research & Publications (20)
Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge Conference.
PMID 18072254·Cancer·2008
8-other
Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: conference summary statement.
PMID 16467115·Clin Cancer Res·2006
8-other
Role of fulvestrant in sequential hormonal therapy for advanced, hormone receptor-positive breast cancer in postmenopausal women.
PMID 15865846·Clin Breast Cancer·2005
6-review
Proceedings of the Fourth International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement.
PMID 15701878·Clin Cancer Res·2005
8-other
Proceedings of the Third International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement.
PMID 14734487·Clin Cancer Res·2004
8-other
Second International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: summary consensus statement.
PMID 12538498·Clin Cancer Res·2003
6-review
Review of gene-expression profiling and its clinical use in breast cancer.
PMID 18614375·Crit Rev Oncol Hematol·2009
6-review
Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer.
PMID 18421051·J Clin Oncol·2008
3-trial
Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactions.
PMID 17345004·Invest New Drugs·2007
3-trial
Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer.
PMID 17317830·Clin Cancer Res·2007
3-trial
Inadvertent use of aromatase inhibitors in patients with breast cancer with residual ovarian function: cases and lessons.
PMID 16800976·Clin Breast Cancer·2006
5-case
Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy.
PMID 16293865·J Clin Oncol·2005
3-trial
Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma: a prospectively planned combined survival analysis of two multicenter trials.
PMID 15937908·Cancer·2005
3-trial
Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial.
PMID 15774786·J Clin Oncol·2005
3-trial
Endocrine treatment options for advanced breast cancer--the role of fulvestrant.
PMID 15691633·Eur J Cancer·2005
4-observational
Pharmacokinetic profile of intramuscular fulvestrant in advanced breast cancer.
PMID 15170367·Clin Pharmacokinet·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 330 BROOKLINE AVE
BOSTON, MA 02215 - Phone
- (617) 667-4599
Quick Facts
- NPI
- 1619940137
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 54
- Publications
- 20
Are you this provider?
Claim Your Profile